1 / 5

P-SATT Leadership Team

American Academy of Pediatrics Provisional Section on Advances in Therapeutics and Technology (P-SATT). P-SATT Leadership Team. Charlie Thompson (Chair), MD FAAP Chair, Executive Committee General Pediatrics Medical Director, Pfizer Inc Brahm Goldstein, MD MCR FAAP

hilel-snider
Download Presentation

P-SATT Leadership Team

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. American Academy of PediatricsProvisional Section on Advances in Therapeutics and Technology(P-SATT)

  2. P-SATT Leadership Team • Charlie Thompson (Chair), MD FAAP • Chair, Executive Committee • General Pediatrics • Medical Director, Pfizer Inc • Brahm Goldstein, MD MCR FAAP • Member, Executive Committee • Chair, Membership & Communication Subcommittee • Pediatric Critical Care • Senior Medical Director, Ikaria Inc • Gwen Levy, MD FAAP • Member, Executive Committee • Program Chair, National Conference & Exhibition • General Pediatrics • Global Safety Medical Director • Amgen • Sam Maldonado, MD FAAP • Chair, Liaison Subcommittee • Pediatric Infectious Diseases • Vice President & Head of Pediatric Drug Development Center of Excellence, Janssen Pharmacuetical Companies • Andrew Mulberg, MD FAAP • Member, Executive Committee • Pediatric Gastroenterology • Division Deputy Director, Gastroenterology and Inborn Errors Products • Food and Drug Administration • Ron Portman, MD FAAP FASN • Member, Executive Committee • Chair, Government Subcommittee • Pediatric Nephrology • Group Director, Bristol-Myers Squibb • Chuck Schubert, MD MPH FAAP • Chair, Safety Subcommittee • General Pediatrics • Senior Medical Director, Patient Safety • AstraZeneca • Stephen Spielberg, MD PhD FAAP • Member, Executive Committee • Chair, Education Subcommittee • Pharmacology • Director, Center for Personalized Medicine and Therapeutic Innovation , Children's Mercy Hospital • Seth Toback, MD FAAP • Newsletter Editor & ListServ Moderator • General Pediatrics • Medical Director, MedImmune • Paul Wang, MD FAAP • Member, Executive Committee • Chair, Research Subcommittee • Behavioral and Developmental Pediatrics • Vice President, Seaside Therapeutics

  3. P-SATT Goals and Objectives • Mission • To advance pediatric health and well-being through collaboration, communication and education on the discovery and development of therapeutics and technology and their successful translation into practice • Goals • Communication • To improve communication and relationships with AAP members within industry, academia and government agencies to create opportunity for dialogue with the organizations that employ them • Education • To educate AAP membership on the discovery, development, and implementation process for therapeutics and technology • Networking • To create a vibrant member community and network that will add value to AAP members • To serve as a resource and integrate expertise with other Sections, Committees and membership-at-large • Integration • To explore the research and development process and make recommendations that will improve quality, safety, understanding and efficiency

  4. P-SATT Proposed 2011 Activities • Communication • Develop a dialogue with AAP Leadership on potential areas of collaboration between the AAP, industry, academia, and government agencies (e.g., FDA) • Education • Educate AAP members about drug discovery and development, clinical research and regulatory issues involving new therapeutics and technology for children • Section education program at 2011 AAP on advancing pediatric medicine • Educate AAP members about alternative career paths (e.g., industry, government) • Networking • Develop strategies to recruit AAP members from diverse background into the Section, connect them to each other, and engage them in a meaningful way in the work of the section • Develop liaisons with other AAP sections and committees • Integration • Explore ways to improve the process of drug/device research and development and its translation to everyday practice • Explore relationships between AAP, industry, academia and government agencies (e.g., FDA)

  5. How To Join P-SATT • If you are a member of the AAP, please follow the instructions below to join our section • 1) Follow the link to the AAP Member Center • http://www.aap.org/moc/memberservices/sectionform.cfm • 2) Log in as an AAP member • 3) Check the box for “Advances in Therapeutics and Technology” and complete the remainder of the form. • If you are not yet an AAP member but are eligible to join, please follow the link below to join the AAP and then follow the section instructions above • http://www.aap.org/member/memcat.htm

More Related